SID 2026Abstract 1032Laboratory research
Baricitinib blocks Th17 cytokines and independently stimulates filaggrin and loricrin expression in new ex vivo platform for IL-23-driven psoriasiform dermatitis
Kenney S, Wu X, Wei D, Hwang S
SID Annual Meeting 2026Preclinical studiesChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Skin biologyJAK inhibitors & other targeted pills
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.1063 · Not in PubMed: details from Crossref